CASI Pharmaceuticals, Inc (DE)
CASIDelisted- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000895051
CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.
13F holders, Q1 2023
Institutional positions in CASI Pharmaceuticals, Inc (DE) as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CASI is no longer listed, and 13F filings after Q4 2022 list far fewer holders. See Q4 2022
- Institutional holders
- 0
- −23 vs. Q4 2022
- Shares held
- 0
- −1.87M (−100.0%) vs. Q4 2022
- Total value
- $0
- −$3.31M (−100.0%) vs. Q4 2022
- New holders
- 0
- 0 more added
- Sold out
- 23
- 0 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CASI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 23 | $3.31M |
| Q3 2022 | 24 | $5.17M |
| Q2 2022 | 24 | $6.26M |
| Q1 2022 | 45 | $18.9M |
| Q4 2021 | 51 | $22.4M |
| Q3 2021 | 59 | $46.0M |
| Q2 2021 | 69 | $72.3M |
| Q1 2021 | 86 | $127.4M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc (DE); share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −900,651−100.0% | Sold out |
| Vanguard Group Inc | 0 | $0 | 0.00% | −257,618−100.0% | Sold out |
| Wellington Shields Capital Management, LLC | 0 | $0 | 0.00% | −206,148−100.0% | Sold out |
| Wellington Shields & Co., LLC | 0 | $0 | 0.00% | −145,315−100.0% | Sold out |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −98,133−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −91,715−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −57,395−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −35,555−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −25,593−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −24,546−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −11,508−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −10,900−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,494−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −1,946−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,423−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −62−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Colonial Trust Co | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |